[SCHEDULE 13G] Forte Biosciences, Inc. SEC Filing

Rhea-AI Filing Summary

Schedule 13G filing for Forte Biosciences, Inc. (NASDAQ: FBRX) discloses that Federated Hermes, Inc., together with the Voting Shares Irrevocable Trust and members of the Donahue family, holds 1,072,233 common shares of FBRX, representing 8.78 % of the outstanding class as of 30 June 2025. The group reports sole voting and dispositive power over the entire position; no shares are reported as shared voting or shared dispositive power.

The filing is made on Schedule 13G, indicating a passive investment intent rather than an attempt to influence control (Schedule 13D). Item 10 certifications affirm the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control. Each reporting person—Federated Hermes (a Pennsylvania parent holding company), the Voting Shares Irrevocable Trust, and individual trustees Thomas R., Ann C. and J. Christopher Donahue—has signed the certification dated 7 July 2025.

Key takeaways for investors:

• Institutional Support: Nearly 9 % stake by a well-known asset-manager-led group may suggest confidence in Forte’s prospects.
• Passive Nature: Schedule 13G signals no activist agenda; limited immediate governance impact.
• Ownership Threshold: The stake exceeds the 5 % disclosure trigger but remains below 10 %, keeping the group under certain regulatory thresholds (e.g., Hart-Scott-Rodino pre-merger filing).

Positive

• Institutional confidence: Federated Hermes and related parties disclosed an 8.78 % stake, adding a respected asset manager to Forte’s shareholder base.

Negative

• None.

Insights

Securities Analyst

TL;DR – Federated Hermes now owns 8.78 % of FBRX; passive filing, limited short-term impact.

This 13G reveals an institutional holder building a meaningful position in Forte Biosciences. While Federated Hermes is a respected asset manager, the filing is passive, so no governance action is implied. The size—just under 9 %—can provide float stability and potential support for future capital raises, yet it does not cross the 10 % insider threshold that could trigger additional reporting or anti-takeover concerns. Overall impact on valuation is modest; the disclosure mainly informs investors of the updated ownership structure and may enhance perceived institutional credibility.

Corporate Governance Expert

TL;DR – Passive stake signals confidence but no control intent; governance status quo.

From a governance standpoint, the Donahue-controlled entities consolidate voting at Federated Hermes, giving them sole power over 8.78 % of shares. Because the stake is reported on Schedule 13G, the group certifies no activist purpose, reducing the likelihood of proxy contests or board pressure. Investors should monitor future filings: any switch to Schedule 13D or movement above 10 % would indicate a shift toward an influential role. At present, the disclosure is routine and non-impactful for corporate control dynamics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

FORTE BIOSCIENCES, INC.

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

34962G208

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Federated Hermes, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,072,233.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,072,233.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,072,233.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.78 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Voting Shares Irrevocable Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,072,233.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,072,233.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,072,233.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.78 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Thomas R. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,072,233.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,072,233.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,072,233.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.78 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Ann C. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,072,233.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,072,233.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,072,233.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.78 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

J. Christopher Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,072,233.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,072,233.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,072,233.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.78 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: FORTE BIOSCIENCES, INC.
(b)	Address of issuer's principal executive offices: 3060 Pegasus Park Drive, Building 6, Dallas, TX 75247
Item 2.
(a)	Name of person filing: Federated Hermes, Inc.
(b)	Address or principal business office or, if none, residence: 1001 Liberty Avenue, Pittsburgh, PA 15222-3779
(c)	Citizenship: Pennsylvania
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 34962G208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,072,233
(b)	Percent of class: 8.78 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,072,233
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,072,233
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit "1" Attached
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Federated Hermes, Inc.

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:	07/07/2025

Voting Shares Irrevocable Trust

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/07/2025

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/07/2025

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/07/2025

Thomas R. Donahue

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue
Date:	07/07/2025

Ann C. Donahue

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue
Date:	07/07/2025

J. Christopher Donahue

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue
Date:	07/07/2025

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY

FAQ

How many Forte Biosciences shares does Federated Hermes own?

The group reports 1,072,233 common shares, equal to 8.78 % of outstanding stock.

Is Federated Hermes acting as an activist in FBRX?

No. The filing is on Schedule 13G, indicating a passive investment with no intent to influence control.

What voting power does the reporting group hold over FBRX shares?

They report sole voting and dispositive power over 1,072,233 shares; shared power is 0.

Does the 8.78 % stake trigger additional regulatory requirements?

The stake exceeds the 5 % disclosure threshold but remains below 10 %, avoiding certain heightened regulatory obligations.

Who signed the Schedule 13G for Federated Hermes?

Signatures include J. Christopher Donahue (President, Federated Hermes) and trustees Thomas R., Ann C., and J. Christopher Donahue for the Voting Shares Irrevocable Trust.